Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Amandine Ruffier
Observed names:
A. Ruffier,
Amandine RUFFIER,
Ruffier, Amandine
Institution:
Centre Jean Bernard
Observed institutions:
Université Paris-Saclay,
Institut Gustave Roussy,
Centre Hospitalier Universitaire de Tours,
Hôpital Bretonneau,
Centre Jean Bernard,
Clinique Victor Hugo
show all 6
ORCID:
0009-0002-5445-9725
Observed ORCID:
0009-0002-5445-9725
OpenAlex ID:
A5018055632
Pembrolizumab versus cetuximab concurrent with radiotherapy in patients with locally advanced squamous cell carcinoma of head and neck unfit for cisplatin (GORTEC 2015-01 PembroRad): a multicenter, randomized, phase II trial
2022
·
Y. Tao
, J. Biau
, et al.
·
Annals of Oncology
·
215
PDF
Weekly Adaptive Radiotherapy vs Standard Intensity-Modulated Radiotherapy for Improving Salivary Function in Patients With Head and Neck Cancer: A Phase 3 Randomized Clinical Trial
2023
·
Joël Castelli
, Juliette Thariat
, et al.
·
JAMA Oncology
·
77
Inter-observer variability in target delineation increases during adaptive treatment of head-and-neck and lung cancer
2019
·
Rudi Apolle
, Steffen Appold
, et al.
·
Acta Oncologica
·
36
PDF
Early toxicity of moderately hypofractionated radiation therapy in breast cancer patients receiving locoregional irradiation: First results of the UNICANCER HypoG-01 phase III trial
2025
·
Thomas Brion
, Robabeh Ghodssighassemabadi
, et al.
·
Radiotherapy and Oncology
·
19
Nouveautés dans la prise en charge des carcinomes nasopharyngés
2018
·
P. Blanchard
, F. Nguyen
, et al.
·
Cancer/Radiothérapie
·
16
Cost-effectiveness of weekly adaptive radiotherapy versus standard IMRT in head and neck cancer alongside the ARTIX trial
2024
·
Lionel Perrier
, Frédéric Balusson
, et al.
·
Radiotherapy and Oncology
·
15
PDF
Long-term outcomes and safety after reirradiation in locally recurrent nasopharyngeal carcinoma in a non-endemic area
2020
·
J. Boustani
, A. Ruffier
, et al.
·
Strahlentherapie und Onkologie
·
15
Prognostic factors in patients with soft palate squamous cell carcinoma
2019
·
Antoine Schernberg
, Charles Canova
, et al.
·
Head & Neck
·
14
5-year results of hypofractionated locoregional radiotherapy in early breast cancer HypoG-01 (UNICANCER): a French multicentre, randomised, non-inferiority, phase 3, open-label, controlled trial
2026
·
Sofia Rivera
, Robabeh Ghodssighassemabadi
, et al.
·
The Lancet
·
11
Randomized phase II trial in prostate cancer with hormone-sensitive OligometaSTatic relapse: Combining stereotactic ablative radiotherapy and durvalumab (POSTCARD GETUG P13): Study protocol
2023
·
Maximilien Rogé
, Yoann Pointreau
, et al.
·
Clinical and Translational Radiation Oncology
·
11
Patient Satisfaction with Fentanyl Pectin Nasal Spray in Breakthrough Cancer Pain Management During Radiotherapy for Head and Neck Cancer
2020
·
Yoann Pointreau
, Rene-Jean Bensadoun
, et al.
·
Patient Preference and Adherence
·
9
PDF
Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma
2019
·
Chengrun Du
, Pierre Blanchard
, et al.
·
Head & Neck
·
9
Long-term recurrences of jaw osteoradionecrosis after apparent healing with the PENTOCLO protocol
2019
·
A. Dinnoo
, F. Bidault
, et al.
·
Journal of Stomatology Oral and Maxillofacial Surgery
·
9
PDF
Reirradiation of gliomas under stereotactic conditions: Prognostic factors for survival without relapse or side effects, a retrospective study at Tours regional university hospital (France)
2017
·
S. Lévy
, S. Chapet
, et al.
·
Cancer/Radiothérapie
·
8
Prediction of the need of enteral nutrition during radiation therapy for head and neck cancers
2024
·
Paul Giraud
, Sebastien Guihard
, et al.
·
Radiotherapy and Oncology
·
7
Organisation française de la radiothérapie pédiatrique : résultats d’une enquête du comité radiothérapie de la Société française des cancers de l’enfant (SFCE)
2016
·
C. Demoor-Goldschmidt
, L. Claude
, et al.
·
Cancer/Radiothérapie
·
7
Hypofractionated split-course versus standard radiotherapy in frail older patients with head and neck squamous-cell carcinoma (ELAN-RT trial): a non-inferiority, multicentre, open-label, randomised controlled trial
2026
·
Cécile Ortholan
, Anne Aupérin
, et al.
·
The Lancet Healthy Longevity
·
6
PDF
Étude et réflexion sur les critères d’admission en unité de soins palliatifs
2009
·
Anne Déglise
, Amandine Ruffier
, et al.
·
Médecine Palliative
·
6
Comprehensive radiotherapy quality assurance analysis from individual DICOM data in the HypoG-01 phase 3 trial
2025
·
Thomas Brion
, Mamadou Balde
, et al.
·
Radiotherapy and Oncology
·
5
ALADDIN: Evaluation of darolutamide addition to androgen deprivation therapy and radiation therapy in newly diagnosed prostate cancer with pelvic lymph nodes metastases.
2024
·
Stephane Oudard
, Pierre Combe
, et al.
·
Journal of Clinical Oncology
·
3
Pushing the Boundaries of Stereotactic Body Radiation Therapy in Irradiated Territories for Nodal Oligorecurrent Prostate Cancer: Outcomes of the CYGNUS Multicentric Retrospective Study
2026
·
Ewen Anger
, Stephane Supiot
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Gender disparities in academic radiation oncology research: A narrative review
2026
·
Lucie Houdou
, Angela Besserer
, et al.
·
Clinical and Translational Radiation Oncology
·
1
PDF
Reirradiation of squamous cell carcinoma of the head and neck with external photons: A practical review of the literature
2024
·
Élodie Queyrel
, Arianne Lapierre
, et al.
·
Cancer/Radiothérapie
·
1
Abstract PO5-21-03: Cosmetic assessment in the UNICANCER HypoG-01 trial: a deep learning approach
2024
·
Alexandre Cafaro
, Amandine Ruffier
, et al.
·
Cancer Research
·
1
Recherche clinique en structure libérale : quelle analyse stratégique ?
2023
·
A. Ruffier
, Y. Pointreau
, et al.
·
Cancer/Radiothérapie
·
1
Show more works
View as search
Works count:
42
Citation count:
507
H-index:
10
I10-index:
10
Year
Topic
Type
